Answers are grounded in this paper and cite their sources.
During October 1988 through January 1990, a study of sporadic Yersinia enterocolitica infections was done in the Oslo region to assess the clinical impact and risk factors for this disease. Sixty-seven case-patients (mean age, 23.4 years) and 132 population-based age- and sex-matched controls were enrolled. Among patients who were well when interviewed, illness lasted a mean of 20 days, but 10% of the others remained symptomatic a year later. Bloody diarrhea occurred only in persons less than 18 years old (P = .002); joint pain was more common in adults (P = .001). Prolonged carriage was found in 47% of patients after resolution of symptoms. Patients were less likely to shed the organism after antimicrobial treatment (relative risk, 0.3; P = .003). Case-patients were more likely than controls to have antecedent enteric illness (odds ratio, 8.2; P less than .001). Y. enterocolitica infection in Norway is notable for its severity and chronicity. Postsymptomatic shedding, which occurs commonly, may be reduced by antimicrobial treatment.
No takes yet. Share an insight, caveat, or question.
Ostroff et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: